Gilead Sciences - 2 Year Dividend Yield History | GILD
Historical dividend payout and yield for Gilead Sciences (GILD) since 2017. The current TTM dividend payout for Gilead Sciences (GILD) as of February 22, 2019 is $2.28. The current dividend yield for Gilead Sciences as of February 22, 2019 is 3.40%.
||Medical - Biomedical and Genetics
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.